STAAR Surgical is trading at $21.32, with a -5.12% change before the October 5 session; the catalyst remains unclear.

  • The latest identifiable company-specific item was Stifel’s September 29 upgrade, which was positive and does not explain the decline.
  • Major U.S. indices are little changed in the supplied context, so broad-market weakness does not clearly account for the move.